cetirizine has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zuraeva, ZT | 1 |
| Vikulova, OK | 1 |
| Malysheva, NM | 1 |
| Nikankina, LV | 1 |
| Zaytceva, NV | 1 |
| Sukhareva, OY | 1 |
| Shamhalova, MS | 1 |
| Shestakova, MV | 1 |
| Mokrysheva, NG | 1 |
| Hogan Ii, RB | 1 |
| Hogan Iii, RB | 1 |
| Cannon, T | 1 |
| Rappai, M | 1 |
| Studdard, J | 1 |
| Paul, D | 1 |
| Dooley, TP | 1 |
| Veraldi, S | 1 |
| Romagnuolo, M | 1 |
| Benzecry, V | 1 |
| Aguilar-Gamboa, FR | 1 |
| Cubas-Alarcon, D | 1 |
| Villegas-Chiroque, M | 1 |
| Failoc-Rojas, VE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) to Evaluate the Safety and Efficacy of Drug Combinations in COVID-19 Patients[NCT05077332] | Phase 2 | 2,000 participants (Anticipated) | Interventional | 2021-12-29 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for cetirizine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
[Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inh | 2023 |
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Cetirizine; Cohort Studies; Coronavirus | 2020 |
Urticaria as a first clinical manifestation of COVID-19.
Topics: Acetaminophen; Adult; Antiviral Agents; Cetirizine; COVID-19; COVID-19 Drug Treatment; Dermatologic | 2020 |
Pityriasis rubra pilaris post-infection due COVID-19: case report.
Topics: Cetirizine; Child, Preschool; COVID-19; Glucocorticoids; Humans; Immunoglobulin G; Male; Pityriasis | 2021 |